A prospective study on children with initial diagnosis of transient hypogammaglobulinemia of infancy: results from the Italian Primary Immunodeficiency Network.
Transient hypogammaglobulinemia of infancy (THI) is a heterogeneous disorder characterized by reduced serum IgG levels in early infancy. A putative diagnosis is initially made after exclusion of other causes of hypogammaglobulinemia while a definitive diagnosis of THI can only be made a posteriori in patients with normalization of IgG levels. The aim of this study is to characterize clinical and immunological features of children with an initial diagnosis of THI in correlation to natural outcome, and to assess predictive laboratory parameters of clinical evolution for this disorder. We prospectively analysed clinical and immunological characteristics of 77 THI children at initial diagnosis and of 57 patients at follow-up. Memory B cell subsets and in vitro immunoglobulin production were evaluated. Seventy patients (91 percent) showed clinical symptoms. Patients suffered from infections (91 percent), allergies (47 percent) and autoimmune disease (4 percent). During follow-up 41/57 children (72 percent) normalized IgG values, mostly within 24 months of age (p less than 0.001), allowing the diagnosis of THI. The 16 children who did not normalize their IgG levels showed a higher frequency of severe infections and autoimmune disease (p less than 0.01). Moreover, they expressed a reduced frequency of IgM and switched memory B cells (p less than 0.01) and an inability to produce IgG in vitro (p less than 0.02). We conclude that most patients with an initial diagnosis of THI spontaneously recover within 24 months of age and have a benign clinical course, while a subgroup of children with undefined hypogammaglobulinemia share a clinical and immunological profile with other primary immunodeficiencies. Early recognition of children with hypogammaglobulinemia during infancy who are likely to suffer from permanent immunodeficiencies later in life would allow prompt and appropriate laboratory and clinical interventions.
Moschese
V
V
Department of Pediatrics, Policlinico Tor Vergata, University of Rome Tor Vergata, Viale Oxford 81, Rome, Italy. moschese@med.uniroma2.it
Graziani
S
S
Avanzini
M A
MA
Carsetti
R
R
Marconi
M
M
La Rocca
M
M
Chini
L
L
Pignata
C
C
Soresina
A R
AR
Consolini
R
R
Bossi
G
G
Trizzino
A
A
Martino
S
S
Cardinale
F
F
Bertolini
P
P
Marseglia
G L
GL
Zecca
M
M
Di Cesare
S
S
Quinti
I
I
Rondelli
R
R
Pietrogrande
M C
MC
Rossi
P
P
Plebani
A
A
D000361:Agammaglobulinemia / Q000453:epidemiology*; D000375:Aging / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D002675:Child, Preschool; D018450:Disease Progression; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007136:Immunoglobulins / Q000096:biosynthesis; D007153:Immunologic Deficiency Syndromes / Q000453:epidemiology*; D007156:Immunologic Memory / Q000276:immunology; D007223:Infant; D007558:Italy / Q000453:epidemiology; D008297:Male; D011446:Prospective Studies; D016896:Treatment Outcome
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins